Jeremy J. Schmalzle
Vice President, HIV Global Strategic Marketing, Gilead Sciences
Jeremy J. Schmalzle is Vice President, HIV Global Strategic Marketing at Gilead Sciences, where he is responsible for defining and executing the integrated global commercial strategy for Gilead’s HIV treatment, prevention, and pipeline portfolio, leading cross-functional and regional alignment to optimize lifecycle management, product development, launch readiness, portfolio prioritization, and long-term business growth. Over a career spanning more than 25 years in the biopharmaceutical industry, he has held leadership roles across commercial strategy, marketing, sales, and product launches in HIV, liver disease, and other therapeutic areas. Jeremy brings extensive experience in healthcare innovation, commercialization, and patient-centered strategy.
He holds a Bachelor of Arts in both Chemistry and International Business from Lehigh University (class of 1997) and a Master's in Business Administration from Rutgers University.